Engineered Viral Vector Targeting Tumor Heat and Low pH
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Cancer cells evade the body's immune system by diminishing signaling mechanisms, allowing them to proliferate and spread, and existing therapies like chemotherapy and radiation therapy suppress the immune system, making them ineffective.
Innovation Solution
A vector-engineered influenza virus is designed to target cancer cells based on their elevated temperature and low pH environment, activating the immune system to attack and destroy cancer cells without harming healthy tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemotherapy and radiation therapy are used to treat cancer, then cancer cells are destroyed, but the immune system is suppressed
Solution Approach 1:
The patent converts the cancer cells' own metabolic characteristics (heat production and acidification) which normally help them survive and proliferate, into beneficial targeting signals that attract and activate immune cells to destroy the tumor. The hypoxic, acidic, and warm tumor microenvironment becomes a beacon for immune recruitment rather than just a survival niche for cancer cells.
Solution Approach 2:
The patent introduces immune cells as intermediaries that bridge the tumor microenvironment and cancer cell destruction. Instead of directly attacking cancer cells with chemotherapy or radiation, the engineered approach uses immune cells to recognize and eliminate tumor cells, thereby destroying cancer while simultaneously strengthening immune surveillance.
2Reliability
If the body's immune system is strengthened to fight cancer, then cancer cells are attacked, but cancer cells can evade immune detection
Solution Approach 1:
The patent effectively changes the 'color' or detectability of cancer cells by exploiting their thermal and pH characteristics. The tumor microenvironment's heat and acidity create a distinct signature that makes cancer cells visible and detectable to immune cells, overcoming their usual ability to evade immune surveillance.
Solution Approach 2:
The patent replaces the mechanical/chemical direct-kill mechanisms of chemotherapy and radiation with a biological detection and response system. Immune cells use their natural sensing capabilities to detect thermal and pH gradients, substituting direct chemical destruction with intelligent biological recognition and targeted elimination.
3Object-affected harmful factors
If a virus is engineered to target cancer cells specifically, then healthy tissue is preserved, but the virus must selectively recognize cancer biomarkers
Solution Approach 1:
The patent applies local quality by engineering the virus to respond to local microenvironmental conditions (temperature and pH) rather than requiring complex recognition of specific cancer cell surface markers. The virus is designed to be activated or to exhibit enhanced activity specifically in the warm, acidic tumor microenvironment, providing selectivity through environmental sensing rather than molecular recognition complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered virus selectively infects cancer cells, triggering the immune system to encapsulate and eliminate tumors, reducing the need for chemotherapy and radiation therapy by leveraging the body's natural defenses.
Implementation Method 1
A vector-engineered influenza virus is designed to target cancer cells based on their elevated temperature and low pH environment
Implementation Method 2
activating the immune system to attack and destroy cancer cells without harming healthy tissue
Implementation Method 3
The virus may kill some infected cells by provoking that individual cell's inherent defenses
Implementation Method 4
one being a higher than normal heat signature from elevated metabolic activity
Implementation Method 5
an acidic or lower than normal pH factor resulting from the hypoxic micro environment resulting from the depletion of all available oxygen
Data Source
AI summary
The present invention provides a vector engineered virus designed to favor and infect cancers and surrounding cells. This technique mitigates cancer's ability to evade the body's immune system by calling attention to the cells that are cancerous beginning with their earliest stage of development by infecting those cells with a vector engineered virus specifically designed to target tumors in formation. This invention teaches a system and method for identifying, tagging, targeting, and destroying cancer cells while preserving healthy tissue. Developing cancers have two primary traits/biomarkers in common; one being a higher than normal heat signature from elevated metabolic activity; with the second being an acidic or lower than normal pH resulting from the hypoxic micro environment resulting from the depletion of available oxygen. Simply stated, all or most cancers have a heat signature greater than that of normal healthy cells and a pH lower than seen around normal healthy cells.